All anti-CD20 monoclonal antibodies have similar efficacy and risks: No
Research output: Contribution to journal › Comment/debate › Research › peer-review
| Original language | English |
|---|---|
| Journal | Multiple Sclerosis Journal |
| Volume | 28 |
| Issue number | 12 |
| Pages (from-to) | 1845-1846 |
| Number of pages | 2 |
| ISSN | 1352-4585 |
| DOIs |
|
| Publication status | Published - 2022 |
ID: 321283638